MPM BIOVENTURES 2018, L.P. sold 1.4% of their position (62.71K shares) of ENTRADA THERAPEUTICS, INC. on the open market
Open‑market sale worth $461.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 8/27/2026ACC: 0001231919-26-001106
10% Owner
Since Oct 2021
-62.71K
Net shares
Net seller
$461.5K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
62.71K disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−21.62K
Price / share
$7.34
Trade value
$158.71K
% of position
0.5%
8/24/2026
4.38M→4.36M
Common Stock
Indirect
Shares
−26.52K
Price / share
$7.54
Trade value
$199.98K
% of position
0.6%
8/25/2026
4.36M→4.33M
Common Stock
Indirect
Shares
−14.57K
Price / share
$7.06
Trade value
$102.86K
% of position
0.3%
8/26/2026
4.33M→4.32M
Total
Net shares
−62.71K
Net value
-$461.55K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/24/2026 | S · Sale | −21.62K | $7.34 | $158.71K | 0.5% | 4.38M | 4.36M |
| Common Stock Indirect | 8/25/2026 | S · Sale | −26.52K | $7.54 | $199.98K | 0.6% | 4.36M | 4.33M |
| Common Stock Indirect | 8/26/2026 | S · Sale | −14.57K | $7.06 | $102.86K | 0.3% | 4.33M | 4.32M |
| Total | −62.71K | -$461.55K | ||||||
Derivative Transactions0
No derivative transactions reported